Report cover image

Dermatophytic Onychomycosis Treatment Market

Publisher Fortune Business Insights Pvt. Ltd.
Published Oct 01, 2024
Length 136 Pages
SKU # FOB19224342

Description

Dermatophytic Onychomycosis Treatment Market



Growth Factors of Dermatophytic Onychomycosis Treatment Market

The dermatophytic onychomycosis treatment market size was valued at USD 4.97 billion in 2023, and the market is now projected to grow from USD 5.34 billion in 2024 to USD 9.52 billion by 2032, exhibiting a CAGR of 7.5% during the forecast period of 2023-2032.

Government has put restrictions on social gatherings, events and moving out from home which make the people homesick. Numerous companies are encountering hurdles due to covid pandemic as the outbreak situation has curtailed production and supply chain which has hindered the market switched to treating covid patients as priority over the other procedures which led the dermatophytic onychomycosis treatment market growth.

Growing rate of dermatophytic onychomycosis will fuel market expansion during projected period. due to rise in number of onychomycosis patients is one of the main factors promoting the dermatophytic onychomycosis treatment market growth in the upcoming years. The presence of potential pipeline candidates to promote market growth. Additionally, podiatrists and dermatologists across the globe believe that there is a critical need for improved topical remedies over those currently available.

The most recent trend is a gradual shift toward topical solutions during projected period. A significant development in the industry is the increasing inclination towards topical treatment options. Patients with heart and liver conditions should not be taken oral antifungal medications due to their link to liver damage. Because of this, effective topical therapies may be the better option in some situations but not in others.

Comprehensive Analysis of Dermatophytic Onychomycosis Treatment Market

The dermatophytic onychomycosis treatment market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the pharmacy benefit management industry. These segmentations are methodically segregated by product types, by route of administration, by type and by distribution channel. The product types segmentations include, Tablets and Nail Paints), By Route of Administration (Oral and Topical), and by Type segmentations include Prescribed and Over-the-Counter (OTC)). However, the Distribution Channel segmentations include Hospital Pharmacies, Retail Pharmacies, and Online Channels.

The North America region lead the dermatophytic onychomycosis treatment market by benefitting a market size of USD 2.20 billion in 2023 due to Growing research, more onychomycosis prescriptions written, and more new medication applications submitted to regulatory bodies.

The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Bausch Health Companies Inc. (Canada), Pfizer Inc. (U.S.), Galderma (Switzerland), GlaxoSmithKline plc (U.K.), Janssen Pharmaceuticals, Inc. (U.S.), Cipla Inc. (India), Kaken Pharmaceuticals Co., Ltd. (Japan) these market players provide a level-playing competitive landscape.

In December 2022, An novel approach to curing onychomycosis has ot patented, as per the statement made by Bausch Health Companies Inc.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

CAGR Growth rate of 7.5% from 2024 to 2032

Unit Volume (K Units)

Segmentation By Product Type
  • Tablets
  • Nail Paints
By Route of Administration
  • Oral
  • Topical
By Type
  • Prescribed
  • Over-the-Counter (OTC
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Channels
By Geography
  • North America (By Product Type, By Route of Administration, By Type, By Distribution Channel, and By Country)
  • U.S.
  • Canada
  • Europe (By Product Type, By Route of Administration, By Type, By Distribution Channel, and By Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Scandinavia
  • Russia
  • Rest of Europe
  • Asia Pacific (By Product Type, By Route of Administration, By Type, By Distribution Channel, and By Country/Sub-region)
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • Southeast Asia
  • Rest of Asia Pacific


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

136 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Epidemiology: Dermatophytic Onychomycosis, Key Countries/ Regions, 2023
4.2. Pipeline Analysis, By Key Players
4.3. New Product Launches, By Key Players
4.4. Key Industry Developments - Mergers, Acquisitions and Partnerships
4.5. Impact of COVID-19 on the Market
5. Global Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Product Type
5.1.1. Tablets
5.1.2. Nail Paints
5.2. Market Analysis, Insights and Forecast – By Route of Administration
5.2.1. Oral
5.2.2. Topical
5.3. Market Analysis, Insights and Forecast – By Type
5.3.1. Prescribed
5.3.2. Over-the-Counter (OTC)
5.4. Market Analysis, Insights and Forecast – By Distribution Channel
5.4.1. Hospital Pharmacies
5.4.2. Retail Pharmacies
5.4.3. Online Channels
5.5. Market Analysis, Insights and Forecast – By Region
5.5.1. North America
5.5.2. Europe
5.5.3. Asia Pacific
5.5.4. Rest of World
6. North America Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Product Type
6.1.1. Tablets
6.1.2. Nail Paints
6.2. Market Analysis, Insights and Forecast – By Route of Administration
6.2.1. Oral
6.2.2. Topical
6.3. Market Analysis, Insights and Forecast – By Type
6.3.1. Prescribed
6.3.2. Over-the-Counter (OTC)
6.4. Market Analysis, Insights and Forecast – By Distribution Channel
6.4.1. Hospital Pharmacies
6.4.2. Retail Pharmacies
6.4.3. Online Channels
6.5. Market Analysis, Insights and Forecast – By Country
6.5.1. U.S.
6.5.2. Canada
7. Europe Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Product Type
7.1.1. Tablets
7.1.2. Nail Paints
7.2. Market Analysis, Insights and Forecast – By Route of Administration
7.2.1. Oral
7.2.2. Topical
7.3. Market Analysis, Insights and Forecast – By Type
7.3.1. Prescribed
7.3.2. Over-the-Counter (OTC)
7.4. Market Analysis, Insights and Forecast – By Distribution Channel
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Channels
7.5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
7.5.1. U.K.
7.5.2. Germany
7.5.3. France
7.5.4. Spain
7.5.5. Italy
7.5.6. Scandinavia
7.5.7. Russia
7.5.8. Rest of Europe
8. Asia Pacific Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Product Type
8.1.1. Tablets
8.1.2. Nail Paints
8.2. Market Analysis, Insights and Forecast – By Route of Administration
8.2.1. Oral
8.2.2. Topical
8.3. Market Analysis, Insights and Forecast – By Type
8.3.1. Prescribed
8.3.2. Over-the-Counter (OTC)
8.4. Market Analysis, Insights and Forecast – By Distribution Channel
8.4.1. Hospital Pharmacies
8.4.2. Retail Pharmacies
8.4.3. Online Channels
8.5. Market Analysis, Insights and Forecast – By Countries/ Sub-region
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. New Zealand
8.5.6. Southeast Asia
8.5.7. Rest of Asia Pacific
9. Rest of World Dermatophytic Onychomycosis Treatment Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Product Type
9.1.1. Tablets
9.1.2. Nail Paints
9.2. Market Analysis, Insights and Forecast – By Route of Administration
9.2.1. Oral
9.2.2. Topical
9.3. Market Analysis, Insights and Forecast – By Type
9.3.1. Prescribed
9.3.2. Over-the-Counter (OTC)
9.4. Market Analysis, Insights and Forecast – By Distribution Channel
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Online Channels
10. Competitive Analysis
10.1. Global Market Share Analysis (2023)
10.2. Company Profiles
10.2.1. GlaxoSmithKline plc
10.2.1.1. Overview
10.2.1.2. Products
10.2.1.3. SWOT analysis
10.2.1.4. Recent Developments
10.2.1.5. Strategies
10.2.1.6. Financials (Based on Availability)
10.2.2. Pfizer Inc.
10.2.2.1. Overview
10.2.2.2. Products
10.2.2.3. SWOT analysis
10.2.2.4. Recent Developments
10.2.2.5. Strategies
10.2.2.6. Financials (Based on Availability)
10.2.3. Galderma
10.2.3.1. Overview
10.2.3.2. Products
10.2.3.3. SWOT analysis
10.2.3.4. Recent Developments
10.2.3.5. Strategies
10.2.3.6. Financials (Based on Availability)
10.2.4. Cipla Inc.
10.2.4.1. Overview
10.2.4.2. Products
10.2.4.3. SWOT analysis
10.2.4.4. Recent Developments
10.2.4.5. Strategies
10.2.4.6. Financials (Based on Availability)
10.2.5. Janssen Pharmaceuticals, Inc.
10.2.5.1. Overview
10.2.5.2. Products
10.2.5.3. SWOT analysis
10.2.5.4. Recent Developments
10.2.5.5. Strategies
10.2.5.6. Financials (Based on Availability)
10.2.6. Kaken Pharmaceuticals Co., Ltd.
10.2.6.1. Overview
10.2.6.2. Products
10.2.6.3. SWOT analysis
10.2.6.4. Recent Developments
10.2.6.5. Strategies
10.2.6.6. Financials (Based on Availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us